Donald Williams - Alphatec Holdings Independent Director
| ATEC Stock | USD 12.34 0.17 1.36% |
Director
Mr. Donald A. Williams is Independent Director of the Company. Mr. Williams is a 36year veteran of the public accounting industry, having spent 18 years as a Partner with Ernst Young LLP and seven years as a Partner with Grant Thornton LLP. Mr. Williams career focused on private and public companies in the technology and life sciences sectors. During his time at Grant Thornton from 2007 to 2014, he served as the national leader of Grant Thorntons life sciences practice and the managing partner of the San Diego Office. He was the lead partner for both Ernst Young and Grant Thornton on multiple initial public offerings, secondary offerings, private and public debt financings, as well as numerous mergers and acquisitions. From 2001 to 2014, Mr. Williams served on the Board of Directors and is past President and Chairman of the San Diego Venture Group. Mr. Williams also serves as a director of Akari Therapeutics Plc, a clinical stage biopharmaceutical company, ImpediMed Ltd, a company that develops bioimpedance devices, Marina Biotech, Inc., a biotechnology company focused on the development of therapeutics for certain disease intersections, and Proove Biosciences, Inc., a research company focused on personalized medicine since 2017.
| Age | 56 |
| Tenure | 7 years |
| Address | 1950 Camino Vida Roble, Carlsbad, CA, United States, 92008 |
| Phone | 760 431 9286 |
| Web | https://www.atecspine.com |
Donald Williams Latest Insider Activity
Tracking and analyzing the buying and selling activities of Donald Williams against Alphatec Holdings stock is an integral part of due diligence when investing in Alphatec Holdings. Donald Williams insider activity provides valuable insight into whether Alphatec Holdings is net buyers or sellers over its current business cycle. Note, Alphatec Holdings insiders must abide by specific rules, including filing SEC forms every time they buy or sell Alphatec Holdings'shares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
Donald Williams over six months ago Western New exotic insider transaction detected |
Alphatec Holdings Management Efficiency
The company has return on total asset (ROA) of (0.1398) % which means that it has lost $0.1398 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (4.1175) %, meaning that it created substantial loss on money invested by shareholders. Alphatec Holdings' management efficiency ratios could be used to measure how well Alphatec Holdings manages its routine affairs as well as how well it operates its assets and liabilities. As of April 19, 2024, Return On Tangible Assets is expected to decline to -0.31. In addition to that, Return On Capital Employed is expected to decline to -0.24. At present, Alphatec Holdings' Total Current Assets are projected to increase significantly based on the last few years of reporting. The current year's Non Current Assets Total is expected to grow to about 371.8 M, whereas Other Assets are forecasted to decline to 0.95.Similar Executives
| Showing other executives | DIRECTOR Age | ||
| Karin Eastham | Illumina | 67 | |
| Joshua Bekenstein | Waters | 56 | |
| Rebecca Chambers | Illumina | N/A | |
| George Scangos | Agilent Technologies | 72 | |
| Wah Chu | Mettler Toledo International | 62 | |
| George Massaro | Charles River Laboratories | 73 | |
| Debora Spar | Thermo Fisher Scientific | 56 | |
| Tyler Jacks | Thermo Fisher Scientific | 59 | |
| Judy Lewent | Thermo Fisher Scientific | 71 | |
| Dion Weisler | Thermo Fisher Scientific | 53 | |
| Stanley Meresman | Guardant Health | 71 | |
| Gary Hendrickson | Waters | 64 | |
| Martin Harris | Thermo Fisher Scientific | 61 | |
| Scott Sperling | Thermo Fisher Scientific | 63 | |
| Michael Berendt | Waters | 71 | |
| Roy Whitfield | Illumina | 63 | |
| JeanPaul Mangeolle | Charles River Laboratories | 57 | |
| Thomas Salice | Mettler Toledo International | 61 | |
| Sue Rataj | Agilent Technologies | 63 | |
| Frances Arnold | Illumina | 61 | |
| Constance Harvey | Mettler Toledo International | 56 | |
Management Performance
| Return On Equity | -4.12 | ||||
| Return On Asset | -0.14 |
Alphatec Holdings Leadership Team
Elected by the shareholders, the Alphatec Holdings' board of directors comprises two types of representatives: Alphatec Holdings inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Alphatec. The board's role is to monitor Alphatec Holdings' management team and ensure that shareholders' interests are well served. Alphatec Holdings' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Alphatec Holdings' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Jeffrey Black, CFO, Executive Vice President | ||
| John Foster, Director | ||
| David Mowry, Independent Director | ||
| Karen McGinnis, Independent Director | ||
| Ali Shorooghi, Senior Marketing | ||
| Jon Allen, Executive Vice President - Commercial Operations | ||
| Leslie Cross, Chairman of the Board | ||
| Rohit Desai, Independent Director | ||
| Stephen ONeil, Independent Director | ||
| Michael ONeill, CFO, Vice President Treasurer | ||
| Stephen Lubischer, VP of Sales | ||
| Michael Plunkett, COO | ||
| Tom Davis, Independent Director | ||
| Donald Williams, Independent Director | ||
| Mortimer Berkowitz, Director | ||
| Kristin Leary, Sr. VP of Global HR | ||
| Jeffrey Rydin, Director | ||
| Terry Rich, CEO, Director | ||
| Jonathan Allen, Executive Vice President - Commercial Operations | ||
| Quentin Blackford, Director | ||
| Siri Marshall, Independent Director | ||
| Christine Zedelmayer, IR Contact Officer | ||
| James Corbett, CEO and President Director and Member of Executive Committee | ||
| Dennis Nelson, Interim Principal Financial and Accounting Officer | ||
| Patrick Miles, Chairman of the Board | ||
| Lance Denardin, Vice President - West | ||
| Scott Lish, Vice President - Development | ||
| Brian Snider, Executive Vice President - Strategic Marketing and Product Development | ||
| Ebun Garner, Senior Vice President General Counsel, Secretary | ||
| James Tullis, Director | ||
| Amy Ables, Vice President - Corporate Education & Performance | ||
| lan Molson, Independent Director | ||
| Michael Dendinger, Vice President - Operations | ||
| Eric Dasso, Executive Technologies | ||
| Evan Bakst, Director | ||
| R Molson, Independent Director | ||
| Tyson Marshall, General Secretary | ||
| David Sponsel, Executive Vice President - Sales | ||
| Mitsuo Asai, President of Alphatec Pacific Inc | ||
| Kelli Howell, Executive Vice President - Clinical Strategies | ||
| Ward Woods, Independent Director | ||
| Luiz Pimenta, Chief Medical Officer | ||
| Craig Hunsaker, Executive Vice President - People and Culture | ||
| Todd Koning, Executive CFO | ||
| Jason Hochberg, Director | ||
| Mark Ojeda, Executive Vice President Cervical and Biologics |
Alphatec Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Alphatec Holdings a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -4.12 | ||||
| Return On Asset | -0.14 | ||||
| Profit Margin | (0.39) % | ||||
| Operating Margin | (0.25) % | ||||
| Current Valuation | 2.05 B | ||||
| Shares Outstanding | 137.98 M | ||||
| Shares Owned By Insiders | 34.75 % | ||||
| Shares Owned By Institutions | 67.15 % | ||||
| Number Of Shares Shorted | 12.36 M | ||||
| Price To Earning | (2.14) X |
Pair Trading with Alphatec Holdings
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Alphatec Holdings position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Alphatec Holdings will appreciate offsetting losses from the drop in the long position's value.Moving together with Alphatec Stock
| 0.83 | EMBC | Embecta Corp Financial Report 10th of May 2024 | PairCorr |
| 0.69 | AHG | Akso Health Group | PairCorr |
Moving against Alphatec Stock
| 0.84 | ELMD | Electromed | PairCorr |
| 0.82 | ALC | Alcon AG Financial Report 14th of May 2024 | PairCorr |
| 0.78 | FEMY | Femasys Financial Report 9th of May 2024 | PairCorr |
| 0.75 | CAH | Cardinal Health Financial Report 2nd of May 2024 | PairCorr |
| 0.71 | GCTK | GlucoTrack | PairCorr |
The ability to find closely correlated positions to Alphatec Holdings could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Alphatec Holdings when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Alphatec Holdings - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Alphatec Holdings to buy it.
The correlation of Alphatec Holdings is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Alphatec Holdings moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Alphatec Holdings moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Alphatec Holdings can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Alphatec Holdings. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in income. For information on how to trade Alphatec Stock refer to our How to Trade Alphatec Stock guide.Note that the Alphatec Holdings information on this page should be used as a complementary analysis to other Alphatec Holdings' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..
Complementary Tools for Alphatec Stock analysis
When running Alphatec Holdings' price analysis, check to measure Alphatec Holdings' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Alphatec Holdings is operating at the current time. Most of Alphatec Holdings' value examination focuses on studying past and present price action to predict the probability of Alphatec Holdings' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Alphatec Holdings' price. Additionally, you may evaluate how the addition of Alphatec Holdings to your portfolios can decrease your overall portfolio volatility.
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like |
Is Alphatec Holdings' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Alphatec Holdings. If investors know Alphatec will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Alphatec Holdings listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.54) | Revenue Per Share 3.978 | Quarterly Revenue Growth 0.302 | Return On Assets (0.14) | Return On Equity (4.12) |
The market value of Alphatec Holdings is measured differently than its book value, which is the value of Alphatec that is recorded on the company's balance sheet. Investors also form their own opinion of Alphatec Holdings' value that differs from its market value or its book value, called intrinsic value, which is Alphatec Holdings' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Alphatec Holdings' market value can be influenced by many factors that don't directly affect Alphatec Holdings' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Alphatec Holdings' value and its price as these two are different measures arrived at by different means. Investors typically determine if Alphatec Holdings is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Alphatec Holdings' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.